Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions

被引：31
作者：
Gerlach, Raquel F. [2 ]
Meschiari, Cesar A. [2 ]
Marcaccini, Andrea M. [2 ]
Palei, Ana C. T. [3 ]
Sandrim, Valeria C. [1 ]
Cavalli, Ricardo C. [4 ]
Tanus-Santos, Jose E. [1 ]
机构：
[1] Univ Sao Paulo, Dept Pharmacol, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Dept Morphol Estomatol & Physiol, Dent Sch Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil
[3] Univ Estadual Campinas, Dept Pharmacol, Fac Med Sci, Campinas, Brazil
[4] Univ Sao Paulo, Dept Gynecol & Obstet, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2009年 / 47卷 / 07期
关键词：
metalloproteinases; plasma; serum; TISSUE INHIBITORS;
D O I：
10.1515/CCLM.2009.203
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：888 / 891
页数：4
相关论文
共 11 条
[1]   Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers [J].
Demacq, Caroline ;
Metzger, Ingrid F. ;
Gerlach, Raquel F. ;
Tanus-Santos, Jose E. .
CLINICA CHIMICA ACTA, 2008, 394 (1-2) :72-76
[2]   Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma [J].
Gerlach, Raquel F. ;
Demacq, Caroline ;
Jung, Klaus ;
Tanus-Santos, Jose E. .
CLINICAL BIOCHEMISTRY, 2007, 40 (1-2) :119-123
[3]   Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities [J].
Gerlach, RF ;
Uzuelli, JA ;
Souza-Tarla, CD ;
Tanus-Santos, JE .
ANALYTICAL BIOCHEMISTRY, 2005, 344 (01) :147-149
[4]   Serum or plasma samples? The "Cinderella" role of blood collection procedures - Preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation [J].
Mannello, Ferdinando .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (04) :611-614
[5]   Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices [J].
Mannello, Ferdinando ;
Tanus-Santos, Jose E. ;
Meschiari, Cesar A. ;
Tonti, Gaetana A. .
ANALYTICAL BIOCHEMISTRY, 2008, 374 (01) :56-63
[6]   Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [J].
Martinez, Marcio L. L. ;
Castro, Michele M. ;
Rizzi, Elen ;
Fernandes, Karla ;
Demacq, Caroline ;
Bendhack, Lusiane M. ;
Gerlach, Raquel F. ;
Tanus-Santos, Jose E. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 591 (1-3) :224-230
[7]   Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension [J].
Martinez, MLL ;
Lopes, LF ;
Coelho, EB ;
Nobre, F ;
Rocha, JBT ;
Gerlach, RF ;
Tanus-Santos, JE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 (01) :117-122
[8]   Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism [J].
Palei, ACT ;
Zaneti, RAG ;
Fortuna, GM ;
Gerlach, RF ;
Tanus-Santos, JE .
ANGIOLOGY, 2005, 56 (05) :611-617
[9]   Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension [J].
Palei, Ana C. T. ;
Sandrim, Valeria C. ;
Cavalli, Ricardo C. ;
Tanus-Santos, Jose E. .
CLINICAL BIOCHEMISTRY, 2008, 41 (10-11) :875-880
[10]   Protective effects of atorvastatin in rat models of acute pulmonary embolism: Involvement of matrix metalloproteinase-9 [J].
Souza-Costa, Debora C. ;
Figueiredo-Lopes, Livia ;
Alves-Filho, Jose C. ;
Semprini, Maria C. ;
Gerlach, Raquel F. ;
Cunha, Fernando Q. ;
Tanus-Santos, Jose E. .
CRITICAL CARE MEDICINE, 2007, 35 (01) :239-245
12